Zdrowie i gospodarka · 13/11/2002
FDA Requests Public Comment on Proposed Collection of Information for New Drug and Biological Products
The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information for approving new drug and biological products based on non-human animal efficacy studies, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →